A gastroenterology research group is evaluating a novel point-of-care salivary assay for celiac disease. During initial clinical validation at a tertiary care celiac referral center, the assay demonstrated a sensitivity of and a specificity of . Based on the specific patient population at this referral center, the positive predictive value of the assay was calculated to be . Following regulatory approval, a large regional primary care network implements the assay for routine screening of asymptomatic adults. Epidemiological data confirms that the true prevalence of celiac disease in this primary care network is exactly one-fifth () of the prevalence observed at the tertiary care referral center. If a patient in the primary care network receives a positive result on this salivary assay, what is the probability that the patient actually has celiac disease?
- A
- B
- Answer
- D
- E